Index RUT P/E - EPS (ttm) -0.52 Insider Own 2.98% Shs Outstand 293.59M Perf Week 4.30%
Market Cap 3.09B Forward P/E 26.89 EPS next Y 0.39 Insider Trans -5.45% Shs Float 287.34M Perf Month -10.17%
Income -151.58M PEG - EPS next Q -0.06 Inst Own 106.44% Short Float 10.90% Perf Quarter -19.72%
Sales 399.36M P/S 7.73 EPS this Y 98.81% Inst Trans -4.32% Short Ratio 10.34 Perf Half Y -10.02%
Book/sh 0.55 P/B 19.10 EPS next Y 6481.79% ROA -20.18% Short Interest 31.32M Perf Year -14.24%
Cash/sh 0.97 P/C 10.78 EPS next 5Y - ROE -107.04% 52W Range 9.70 - 14.57 Perf YTD -26.57%
Dividend Est. - P/FCF - EPS past 5Y 22.84% ROI -25.39% 52W High -28.48% Beta 0.75
Dividend TTM - Quick Ratio 2.52 Sales past 5Y 37.81% Gross Margin 88.68% 52W Low 7.42% ATR (14) 0.35
Dividend Ex-Date - Current Ratio 2.88 EPS Y/Y TTM 37.05% Oper. Margin -18.40% RSI (14) 41.36 Volatility 3.49% 2.95%
Employees 517 Debt/Eq 2.78 Sales Y/Y TTM 21.30% Profit Margin -37.96% Recom 1.55 Target Price 18.78
Option/Short Yes / Yes LT Debt/Eq 2.73 EPS Q/Q 41.97% Payout - Rel Volume 0.79 Prev Close 10.34
Sales Surprise 0.64% EPS Surprise -90.31% Sales Q/Q 30.63% Earnings May 09 BMO Avg Volume 3.03M Price 10.42
SMA20 -1.69% SMA50 -9.54% SMA200 -14.02% Trades
Volume 2,380,727 Change 0.77%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-19-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$15 → $20
Sep-09-22 Initiated Morgan Stanley
Equal-Weight
$14
Apr-13-22 Resumed Goldman
Neutral
$11
Jan-14-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$12 → $16
Nov-15-21 Upgrade Stifel
Hold → Buy
$12 → $16
Sep-30-21 Upgrade JP Morgan
Neutral → Overweight
$16
Jul-19-21 Resumed BTIG Research
Buy
$15
May-27-21 Initiated Needham
Hold
May-21-21 Initiated UBS
Buy
$16
Apr-14-21 Upgrade Cantor Fitzgerald
Neutral → Overweight
$17
Mar-02-21 Initiated Stifel
Hold
$13
Feb-12-21 Downgrade JP Morgan
Overweight → Neutral
$19
Feb-12-21 Downgrade Cantor Fitzgerald
Overweight → Neutral
$30 → $17
Dec-28-20 Resumed Cantor Fitzgerald
Overweight
$20 → $30
Dec-10-20 Downgrade Citigroup
Buy → Neutral
$20 → $27
Nov-11-20 Initiated Berenberg
Hold
Jun-17-20 Initiated BTIG Research
Buy
$19
Feb-04-20 Resumed Cantor Fitzgerald
Overweight
$19 → $20
Nov-12-19 Reiterated H.C. Wainwright
Buy
$18 → $20
Jun-17-19 Initiated H.C. Wainwright
Buy
$18
Show Previous Ratings
May-01-24 10:01AM
07:00AM
Mar-29-24 11:30AM
Mar-26-24 09:53AM
Mar-20-24 07:00AM
07:07AM
Loading…
Mar-13-24 07:07AM
Mar-06-24 11:56PM
Mar-05-24 01:50PM
(Investor's Business Daily)
Mar-01-24 07:00AM
Feb-29-24 11:25AM
11:23AM
Feb-28-24 11:49PM
(Thomson Reuters StreetEvents) -6.50%
08:20AM
07:32AM
07:00AM
07:00AM
Loading…
Feb-15-24 07:00AM
Feb-09-24 03:14PM
(Investor's Business Daily)
Feb-08-24 07:00AM
Feb-01-24 07:00AM
Jan-12-24 11:02PM
09:31AM
Jan-08-24 09:40AM
Jan-07-24 04:00PM
Jan-05-24 07:02PM
Jan-03-24 11:46AM
07:00AM
Dec-30-23 09:01AM
Dec-29-23 09:48AM
07:01AM
Dec-24-23 06:17AM
05:01AM
Loading…
Dec-21-23 05:01AM
Dec-08-23 11:30AM
Dec-05-23 06:38AM
06:00AM
05:30AM
(The Wall Street Journal)
Nov-15-23 09:48AM
Nov-10-23 10:07AM
Nov-09-23 01:02PM
Nov-08-23 07:13AM
(Associated Press Finance)
07:00AM
Nov-04-23 05:03AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
07:00AM
Oct-27-23 07:00AM
Oct-08-23 07:00AM
Oct-05-23 07:45PM
03:01AM
Oct-03-23 07:00AM
Oct-02-23 08:20AM
Oct-01-23 08:30PM
Sep-29-23 12:22PM
(Associated Press Finance)
09:09AM
Sep-28-23 11:08AM
10:50AM
10:41AM
10:32AM
(Investor's Business Daily)
Sep-21-23 08:42AM
Sep-07-23 11:30AM
Sep-01-23 07:00AM
Aug-29-23 07:00AM
Aug-21-23 07:00AM
Aug-15-23 07:00AM
Aug-09-23 09:25AM
Aug-08-23 08:40AM
07:29AM
07:00AM
Aug-07-23 08:48AM
Aug-04-23 08:05AM
Jul-31-23 07:00AM
Jul-23-23 10:23AM
Jul-20-23 02:24PM
(Investor's Business Daily)
Jul-17-23 01:54PM
(Investor's Business Daily)
Jun-28-23 10:53AM
Jun-27-23 07:00AM
Jun-09-23 11:30AM
Jun-04-23 09:59AM
May-11-23 07:44AM
May-10-23 08:15AM
07:10AM
07:00AM
May-08-23 10:00AM
May-02-23 07:00AM
May-01-23 10:01AM
07:00AM
Apr-26-23 01:00PM
Apr-18-23 09:20AM
Apr-14-23 02:45PM
Mar-31-23 11:30AM
Mar-27-23 07:00AM
Mar-08-23 07:00AM
Mar-02-23 11:39AM
04:28AM
(Thomson Reuters StreetEvents)
Mar-01-23 09:35AM
07:00AM
Feb-27-23 07:00AM
Feb-22-23 05:00PM
Feb-14-23 07:00AM
Feb-13-23 07:00AM
Feb-12-23 07:33AM
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Campbell Bradley L President and CEO May 01 '24 Option Exercise 8.61 7,500 64,575 894,154 May 03 05:21 PM Campbell Bradley L President and CEO May 01 '24 Sale 10.07 7,500 75,524 886,654 May 03 05:21 PM Campbell Bradley L President and CEO Apr 01 '24 Option Exercise 8.61 7,500 64,575 894,154 Apr 03 06:14 PM Campbell Bradley L President and CEO Apr 01 '24 Sale 11.67 7,500 87,496 886,654 Apr 03 06:14 PM SBLENDORIO GLENN Director Mar 07 '24 Option Exercise 2.80 15,000 42,000 83,596 Mar 11 05:36 PM RAAB MICHAEL Director Mar 05 '24 Option Exercise 2.80 15,000 42,000 83,596 Mar 06 05:22 PM MCGLYNN MARGARET G Director Mar 05 '24 Option Exercise 2.80 7,500 21,000 66,789 Mar 06 05:21 PM MCGLYNN MARGARET G Director Mar 05 '24 Sale 13.40 7,500 100,500 59,289 Mar 06 05:21 PM MCGLYNN MARGARET G Director Mar 04 '24 Option Exercise 2.80 7,500 21,000 66,789 Mar 06 05:21 PM MCGLYNN MARGARET G Director Mar 04 '24 Sale 13.29 7,500 99,675 59,289 Mar 06 05:21 PM Campbell Bradley L President and CEO Mar 01 '24 Option Exercise 10.54 15,833 166,904 887,052 Mar 05 05:14 PM Crowley John F Executive Chairman Mar 01 '24 Sale 13.35 29,181 389,543 573,478 Mar 05 05:14 PM Campbell Bradley L President and CEO Mar 01 '24 Sale 13.14 15,833 208,017 871,219 Mar 05 05:14 PM Crowley John F Executive Chairman Feb 15 '24 Sale 13.81 31,614 436,551 697,628 Feb 20 05:23 PM Clark David Michael Chief People Officer Feb 15 '24 Sale 14.00 4,427 61,978 253,664 Feb 20 05:20 PM Campbell Bradley L President and CEO Feb 15 '24 Sale 14.00 4,167 58,338 871,219 Feb 20 05:21 PM Rosenberg Ellen Chief Legal Officer Feb 07 '24 Option Exercise 5.16 29,600 152,736 397,254 Feb 08 04:40 PM Rosenberg Ellen Chief Legal Officer Feb 07 '24 Sale 13.00 29,600 384,818 367,654 Feb 08 04:40 PM Rosenberg Ellen Chief Legal Officer Feb 06 '24 Option Exercise 5.16 400 2,064 368,054 Feb 08 04:40 PM Rosenberg Ellen Chief Legal Officer Feb 06 '24 Sale 13.00 400 5,200 367,654 Feb 08 04:40 PM Campbell Bradley L President and CEO Feb 01 '24 Option Exercise 10.54 15,833 166,904 891,219 Feb 05 07:22 PM Crowley John F Executive Chairman Feb 01 '24 Sale 12.62 31,614 398,918 750,838 Feb 05 07:22 PM Campbell Bradley L President and CEO Feb 01 '24 Sale 12.56 15,833 198,858 875,386 Feb 05 07:22 PM Crowley John F Executive Chairman Jan 22 '24 Sale 12.36 55,327 683,958 782,452 Jan 24 05:20 PM Crowley John F Executive Chairman Jan 16 '24 Sale 12.78 31,614 404,106 837,779 Jan 18 05:09 PM Crowley John F Executive Chairman Jan 10 '24 Sale 13.65 31,614 431,452 869,393 Jan 11 06:33 PM Clark David Michael Chief People Officer Jan 09 '24 Sale 14.00 1,384 19,376 266,705 Jan 09 06:08 PM Prout Samantha Chief Accounting Officer Jan 09 '24 Sale 14.00 1,337 18,718 80,953 Jan 09 06:07 PM Prout Samantha Chief Accounting Officer Jan 08 '24 Sale 14.00 30,767 430,827 82,290 Jan 09 06:07 PM Clark David Michael Chief People Officer Jan 08 '24 Sale 14.00 8,726 122,164 268,089 Jan 09 06:08 PM Campbell Bradley L President and CEO Jan 02 '24 Option Exercise 10.54 15,833 166,904 956,138 Jan 04 06:35 PM Rosenberg Ellen Chief Legal Officer Jan 02 '24 Option Exercise 5.16 30,000 154,800 372,285 Jan 04 06:24 PM Rosenberg Ellen Chief Legal Officer Jan 02 '24 Sale 14.21 30,000 426,219 342,285 Jan 04 06:24 PM Campbell Bradley L President and CEO Jan 02 '24 Sale 14.23 15,833 225,380 947,805 Jan 04 06:35 PM Castelli Jeff Chief Development Officer Dec 28 '23 Sale 14.52 17,421 252,902 340,661 Dec 29 05:18 PM Rosenberg Ellen Chief Legal Officer Dec 27 '23 Option Exercise 5.16 5,000 25,800 347,285 Dec 28 05:08 PM Rosenberg Ellen Chief Legal Officer Dec 27 '23 Sale 14.07 5,000 70,327 342,285 Dec 28 05:08 PM Rosenberg Ellen Chief Legal Officer Dec 26 '23 Option Exercise 5.16 30,000 154,800 372,285 Dec 28 05:08 PM Rosenberg Ellen Chief Legal Officer Dec 26 '23 Sale 14.00 30,000 420,084 342,285 Dec 28 05:08 PM Prout Samantha Chief Accounting Officer Dec 26 '23 Sale 14.00 7,659 107,228 121,912 Dec 28 05:09 PM Castelli Jeff Chief Development Officer Dec 20 '23 Sale 13.10 1,654 21,667 358,082 Dec 20 04:41 PM Castelli Jeff Chief Development Officer Dec 19 '23 Sale 13.25 17,500 231,875 359,736 Dec 20 04:41 PM Crowley John F Executive Chairman Dec 15 '23 Sale 12.66 6,043 76,516 877,748 Dec 19 05:55 PM Campbell Bradley L President and CEO Dec 01 '23 Option Exercise 2.94 11,702 34,404 803,863 Dec 05 05:07 PM Campbell Bradley L President and CEO Dec 01 '23 Sale 11.08 11,702 129,693 792,161 Dec 05 05:07 PM Crowley John F Executive Chairman Dec 01 '23 Sale 11.08 6,043 66,956 883,791 Dec 05 05:03 PM Crowley John F Executive Chairman Nov 15 '23 Sale 10.84 6,043 65,497 889,834 Nov 17 05:23 PM Campbell Bradley L President and CEO Nov 01 '23 Option Exercise 2.94 11,700 34,398 803,861 Nov 03 07:38 PM Campbell Bradley L President and CEO Nov 01 '23 Sale 10.97 11,700 128,391 792,161 Nov 03 07:38 PM Crowley John F Executive Chairman Nov 01 '23 Sale 10.97 6,044 66,327 895,877 Nov 03 07:37 PM Crowley John F Executive Chairman Oct 16 '23 Sale 10.50 6,044 63,449 901,921 Oct 18 07:57 PM Campbell Bradley L President & CEO Oct 02 '23 Option Exercise 2.94 11,700 34,398 803,861 Oct 04 06:57 PM Campbell Bradley L President & CEO Oct 02 '23 Sale 11.24 11,700 131,489 792,161 Oct 04 06:57 PM Crowley John F Executive Chairman Oct 02 '23 Sale 11.25 6,044 67,967 907,965 Oct 04 06:58 PM Crowley John F Executive Chairman Sep 15 '23 Sale 13.06 6,044 78,964 914,009 Sep 18 05:09 PM Campbell Bradley L President & CEO Sep 01 '23 Option Exercise 2.94 11,700 34,398 810,254 Sep 06 05:29 PM Campbell Bradley L President & CEO Sep 01 '23 Sale 12.97 18,093 234,648 792,161 Sep 06 05:29 PM Crowley John F Executive Chairman Sep 01 '23 Sale 12.98 6,044 78,447 920,053 Sep 06 05:31 PM Crowley John F Executive Chairman Aug 15 '23 Sale 13.03 6,044 78,734 926,097 Aug 16 05:33 PM Prout Samantha Chief Accounting Officer Aug 09 '23 Option Exercise 11.03 36,909 407,116 173,912 Aug 11 05:28 PM Prout Samantha Chief Accounting Officer Aug 09 '23 Sale 14.01 36,909 516,933 137,003 Aug 11 05:28 PM Campbell Bradley L President & CEO Aug 01 '23 Option Exercise 2.94 11,700 34,398 818,554 Aug 03 05:09 PM Campbell Bradley L President & CEO Aug 01 '23 Sale 13.39 20,000 267,874 798,554 Aug 03 05:09 PM Crowley John F Executive Chairman Aug 01 '23 Sale 13.35 6,044 80,716 932,141 Aug 03 05:10 PM Crowley John F Executive Chairman Jul 17 '23 Sale 13.45 6,044 81,263 938,185 Jul 19 05:45 PM Campbell Bradley L President & CEO Jul 13 '23 Sale 12.51 6,800 85,091 806,854 Jul 14 05:06 PM Campbell Bradley L President & CEO Jul 12 '23 Sale 12.51 1,500 18,759 813,654 Jul 14 05:06 PM Campbell Bradley L President & CEO Jul 03 '23 Option Exercise 2.94 11,700 34,398 826,854 Jul 06 06:25 PM Campbell Bradley L President & CEO Jul 03 '23 Sale 12.31 11,700 144,016 815,154 Jul 06 06:25 PM Crowley John F Executive Chairman Jul 03 '23 Sale 12.31 6,044 74,406 944,229 Jul 06 06:26 PM Crowley John F Executive Chairman Jun 15 '23 Sale 13.04 6,044 78,814 950,273 Jun 20 05:18 PM Campbell Bradley L President & CEO Jun 06 '23 Sale 12.50 8,300 103,777 815,154 Jun 08 05:26 PM Campbell Bradley L President & CEO Jun 01 '23 Option Exercise 2.64 11,700 30,907 835,154 Jun 05 07:16 PM Campbell Bradley L President & CEO Jun 01 '23 Sale 11.36 11,700 132,942 823,454 Jun 05 07:16 PM Crowley John F Executive Chairman Jun 01 '23 Sale 11.36 6,044 68,657 956,317 Jun 05 07:16 PM SBLENDORIO GLENN Director May 18 '23 Option Exercise 3.32 15,000 49,800 86,719 May 19 05:13 PM Crowley John F Executive Chairman May 15 '23 Sale 11.18 6,044 67,577 962,361 May 17 06:20 PM
Index - P/E - EPS (ttm) -19.90 Insider Own 5.78% Shs Outstand 4.76M Perf Week 4.70%
Market Cap 69.75M Forward P/E 2.13 EPS next Y 6.80 Insider Trans 0.51% Shs Float 4.54M Perf Month -10.07%
Income -95.63M PEG - EPS next Q 1.23 Inst Own 31.41% Short Float 2.96% Perf Quarter -21.87%
Sales 371.34M P/S 0.19 EPS this Y 222148.48% Inst Trans -43.37% Short Ratio 6.35 Perf Half Y 11.72%
Book/sh 11.80 P/B 1.23 EPS next Y 19.72% ROA -14.81% Short Interest 0.13M Perf Year -23.13%
Cash/sh 4.76 P/C 3.04 EPS next 5Y 20.00% ROE -27.55% 52W Range 9.60 - 21.20 Perf YTD -13.35%
Dividend Est. - P/FCF 2.55 EPS past 5Y 18.48% ROI -35.82% 52W High -31.75% Beta 1.02
Dividend TTM - Quick Ratio 0.54 Sales past 5Y -2.29% Gross Margin 42.56% 52W Low 50.73% ATR (14) 0.79
Dividend Ex-Date - Current Ratio 0.54 EPS Y/Y TTM -12.75% Oper. Margin 3.32% RSI (14) 45.55 Volatility 4.97% 5.09%
Employees 1250 Debt/Eq 0.19 Sales Y/Y TTM -1.35% Profit Margin -25.75% Recom 1.67 Target Price 22.00
Option/Short No / Yes LT Debt/Eq 0.09 EPS Q/Q -731.50% Payout - Rel Volume 1.62 Prev Close 14.07
Sales Surprise -2.73% EPS Surprise -185.61% Sales Q/Q -3.20% Earnings May 07 AMC Avg Volume 21.16K Price 14.47
SMA20 -1.60% SMA50 -9.16% SMA200 -3.21% Trades
Volume 34,381 Change 2.84%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-10-21 Reiterated Needham
Buy
$6 → $4.50
Jun-28-21 Initiated Craig Hallum
Buy
$7
Jan-11-21 Upgrade Loop Capital
Hold → Buy
$3 → $4
Feb-28-20 Reiterated Aegis Capital
Buy
$7 → $8
May-10-19 Reiterated Needham
Buy
$28 → $15
Apr-02-19 Reiterated Aegis Capital
Buy
$30 → $25
Apr-01-19 Downgrade SunTrust
Buy → Hold
Apr-01-19 Downgrade Loop Capital
Buy → Hold
Mar-04-19 Resumed SunTrust
Buy
$27
Mar-01-19 Reiterated Needham
Buy
$20 → $28
Nov-29-18 Initiated Needham
Buy
$20
Oct-11-18 Initiated Aegis Capital
Buy
$29
Jun-12-18 Initiated Loop Capital
Buy
$32
Show Previous Ratings
Today 06:10PM
04:05PM
May-06-24 01:01PM
10:20AM
May-04-24 09:21AM
10:58AM
Loading…
May-03-24 10:58AM
May-02-24 03:29PM
12:53PM
Apr-22-24 08:00AM
07:00AM
Apr-19-24 08:44PM
Apr-05-24 09:35AM
Apr-03-24 08:11AM
Mar-27-24 11:24AM
Mar-20-24 08:00AM
09:00AM
Loading…
Mar-12-24 09:00AM
Mar-07-24 10:52AM
08:42AM
(Thomson Reuters StreetEvents)
Mar-06-24 09:54PM
05:10PM
04:00PM
02:56AM
Mar-05-24 10:54AM
Mar-01-24 08:30AM
Feb-29-24 08:33PM
Feb-23-24 08:00AM
Feb-22-24 08:00AM
Feb-21-24 11:43PM
(Thomson Reuters StreetEvents)
Feb-18-24 03:09PM
(The Wall Street Journal)
Feb-06-24 12:54PM
09:30AM
Loading…
Jan-31-24 09:30AM
Jan-23-24 09:00AM
Jan-16-24 09:00AM
Jan-10-24 10:06AM
Dec-29-23 04:00PM
Dec-27-23 04:29PM
09:37AM
Dec-24-23 03:39PM
Dec-20-23 11:52AM
11:51AM
11:51AM
Dec-18-23 08:00AM
Nov-30-23 08:00AM
Nov-07-23 09:30AM
08:00AM
07:32AM
(Thomson Reuters StreetEvents)
Nov-06-23 04:39PM
04:10PM
Oct-31-23 09:31AM
09:00AM
Oct-26-23 08:00AM
12:24AM
Oct-25-23 08:00AM
Oct-24-23 09:00AM
Sep-26-23 09:00AM
Sep-12-23 08:00AM
Aug-29-23 08:42AM
Aug-21-23 02:07PM
Aug-18-23 03:28AM
Aug-10-23 09:43AM
Aug-09-23 03:19PM
(American City Business Journals) +9.75%
09:28AM
(Thomson Reuters StreetEvents)
Aug-08-23 08:05PM
04:02PM
Jul-21-23 07:00AM
Jul-17-23 08:59AM
Jul-14-23 06:07AM
Jun-14-23 11:03AM
Jun-13-23 09:00AM
Jun-07-23 07:00AM
May-24-23 07:00AM
May-20-23 08:25AM
May-18-23 10:00AM
09:55AM
May-17-23 09:35AM
May-16-23 07:00AM
07:00AM
May-11-23 09:35AM
May-10-23 09:25AM
(Thomson Reuters StreetEvents) -9.13%
May-09-23 06:35PM
04:15PM
May-04-23 09:00AM
08:05AM
Apr-26-23 08:15AM
Apr-25-23 07:00AM
Mar-28-23 09:00AM
Mar-23-23 07:00AM
Mar-01-23 07:11AM
(Thomson Reuters StreetEvents)
Feb-28-23 07:55PM
04:05PM
06:43AM
Feb-27-23 11:42AM
06:50AM
Feb-24-23 07:17AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 08:00AM
06:27AM
Feb-16-23 07:28AM
comScore, Inc. is a global information and analytics company, which engages in the measurement of audiences, consumer behavior, and advertising across media platforms. The company was founded by Magid M. Abraham and Gian Mark Fulgoni in August 1999 and is headquartered in Reston, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
180 DEGREE CAPITAL CORP. /NY/ See Explanation of Responses Apr 03 '24 Buy 14.94 1,417 21,170 27,542 Apr 05 08:26 AM ALGRANATI DAVID Chief Innovation Officer Mar 10 '24 Option Exercise 0.00 2,360 0 13,486 Mar 12 06:48 PM Carpenter Jonathan Chief Executive Officer Nov 29 '23 Option Exercise 0.00 150,659 0 332,318 Nov 30 04:28 PM Curry Mary Margaret See Remarks Aug 17 '23 Buy 0.73 15,000 10,950 36,867 Aug 21 07:15 AM Wendling Brian J Director Aug 17 '23 Buy 0.73 10,353 7,558 267,069 Aug 17 04:05 PM Wendling Brian J Director Aug 16 '23 Buy 0.76 39,647 30,132 256,716 Aug 17 04:05 PM Carpenter Jonathan Chief Executive Officer Aug 16 '23 Buy 0.77 5,000 3,850 181,659 Aug 17 08:38 AM Carpenter Jonathan Chief Executive Officer Aug 11 '23 Buy 0.81 7,500 6,075 176,659 Aug 15 04:14 PM Patterson Martin Edward Director Jun 20 '23 Buy 0.89 9,000 8,010 190,569 Jun 21 08:11 PM CHARTER COMMUNICATIONS, INC. / 10% Owner Jun 15 '23 Option Exercise 0.00 200,000 0 344,246 Jun 16 05:06 PM Patterson Martin Edward Director Jun 15 '23 Option Exercise 0.00 100,000 0 181,569 Jun 16 07:42 PM Wendling Brian J Director Jun 15 '23 Option Exercise 0.00 100,000 0 217,069 Jun 16 07:43 PM Banerjee Nana Director Jun 15 '23 Option Exercise 0.00 100,000 0 129,400 Jun 16 07:41 PM FISHER ITZHAK Director Jun 15 '23 Option Exercise 0.00 100,000 0 277,069 Jun 16 07:42 PM Love Kathleen Director Jun 15 '23 Option Exercise 0.00 100,000 0 281,431 Jun 16 07:40 PM Rosenthal Brent David Director Jun 15 '23 Option Exercise 0.00 100,000 0 929,699 Jun 16 07:41 PM LIVEK WILLIAM PAUL Director Jun 15 '23 Option Exercise 0.00 100,000 0 3,723,261 Jun 16 07:39 PM Gillin Leslie Director Jun 15 '23 Option Exercise 0.00 84,000 0 84,000 Jun 16 07:40 PM LIVEK WILLIAM PAUL Director May 19 '23 Buy 0.98 175,642 172,129 3,623,261 May 22 08:22 AM LIVEK WILLIAM PAUL Director May 18 '23 Buy 0.88 124,358 109,435 3,447,619 May 22 08:22 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
